News Releases

Florham Park, NJ, June 17, 2025 – BASF opens its new Good Manufacturing Practice (GMP) Solution Center, in Wyandotte, Michigan. This investment underscores the ongoing commitment of BASF to providing innovative solutions in the biopharma and pharmaceutical ingredients industries, including the reliable supply of bioprocessing ingredients and excipients for biopharma applications as well as small molecules.
This News Release is only available in English.

Ludwigshafen, Germany – BASF Aroma Ingredients has successfully launched L-Menthol FCC rPCF as its first product with a reduced Product Carbon Footprint (rPCF). Further rPCF product launches are planned to help customers achieve their ambitious Scope 3 carbon reduction targets. BASF's rPCF aroma ingredients come with a PCF reduction of about 10 to 15% compared to conventional BASF products.

The globally recognized climate change organization and product carbon footprint (PCF) verifier “the Carbon Trust” has verified the BASF products 1,6-hexanediol (HDO), formic acid (FA), propionic acid (PA) and neopentyl glycol (NPG). The products have therefore achieved the Carbon Trust label and Lower than Market claim. This confirms that the products have a cradle-to-gate PCF that is demonstrably lower than the market average for fossil-based equivalent products. The verification is valid until May 2026. For PA and NPG, the verification only applies to the European production.

BASF will expand its biomass balance offering to include BMBCert^TM 1,4-butanediol (BDO), tetra­hydrofuran (THF), polytetra­hydrofuran (PolyTHF^®) and 3-(di­methyl­amino)pro­pyl­amine (DMAPA). In addition to the production site in Ludwigshafen, Germany, the site in Geismar, Louisiana, has also achieved certifications for all these products. The Ulsan site in South Korea has obtained certification for PolyTHF. With these certifications, BASF can now offer its customers regionally produced ISCC PLUS and REDcert²-certified products for which renewable resources replace fossil feedstock and additionally reduce the cradle-to-gate product carbon footprint (PCF).

IFF’s and BASF’s Pharma Solutions divisions have joined forces in a collaboration to onboard IFF’s leading product brands in pharmaceutical excipients on BASF’s Virtual Pharma Assistant platform – ZoomLab™. The platform is a science-based digital tool designed to rapidly and accurately predict the best excipients needed for the development of new pharmaceutical formulations to help overcome formulation challenges.